1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL SOFT-TISSUE REPAIR MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASE IN HEALTHCARE EXPENDITURE
3.1.2. INCREASING INCIDENCES OF SOFT TISSUE INJURIES
3.1.3. RISING AGING POPULATION
3.1.4. GROWING DEMAND FOR BIOLOGICS IN SOFT TISSUE REPAIR
3.2. MARKET RESTRAINTS
3.2.1. VARYING REGULATORY COMPLIANCE RULES OF DIFFERENT COUNTRIES
3.2.2. UNSATISFACTORY PATIENT OUTCOMES
3.3. MARKET OPPORTUNITIES
3.3.1. EMERGING ECONOMIES
3.3.2. NEW INNOVATIONS IN SOFT TISSUE REPAIR & TECHNOLOGICAL ENHANCEMENTS IN SURGICAL PRODUCTS
3.4. MARKET CHALLENGES
3.4.1. INCREASING COST OF SURGICAL PROCEDURES
3.4.2. COMPETITION FROM REGIONAL PLAYERS
4. MARKET SEGMENTATION
4.1. GLOBAL SOFT-TISSUE REPAIR MARKETBY APPLICATION
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL DURAL REPARATION MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL HERNIA REPAIR MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL SKIN REPARATION MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.1.5.4. GLOBAL ORTHOPAEDICS MARKET
4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.4.4. KEY CONCLUSIONS
4.1.5.5. GLOBAL VAGINAL SLING PROCEDURES MARKET
4.1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.5.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.5.4. KEY CONCLUSIONS
4.1.5.6. GLOBAL DENTAL MARKET
4.1.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.6.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.6.4. KEY CONCLUSIONS
4.1.5.7. GLOBAL BREAST REFORM PROCEDURES MARKET
4.1.5.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.7.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.7.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.7.4. KEY CONCLUSIONS
4.2. GLOBAL SOFT-TISSUE REPAIR MARKET BY PRODUCT
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL LAPARPSCOPIC INSTRUMENTS MARKET
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL TISSUE PATCH MARKET
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBAL SOFT TISSUE FIXATION DEVICE MARKET
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.3.4. KEY CONCLUSIONS
4.2.5.4. GLOBAL OTHER PRODUCTS MARKET
4.2.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.4.4. KEY CONCLUSIONS
4.3. GLOBAL SOFT-TISSUE REPAIR MARKET BY END-USER
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL HOSPITALS MARKET
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL AMBULATORY SURGICAL CENTERS MARKET
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.3. GLOBAL CLINICS MARKET
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.3.4. KEY CONCLUSIONS
4.3.5.4. GLOBAL OTHER END USERS MARKET
4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.4.4. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHIC ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL SOFT TISSUE REPAIR MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. SMITH & NEPHEW PLC
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. C. R. BARD INC.,
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. LIFE CELL CORPORATION
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. WRIGHT MEDICAL
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. JHONSON & JHONSON
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. LIFENET HEALTH INC.,
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. ARTHREX INC.,
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. COVIDIEN PLC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. INTEGRA LIFESCIENCES CORPORATION
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. AMERICAN MEDICAL SYSTEMS INC.,
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. ARTHRO CARE
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. BIOMET
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. DEPUEY SYNTHES
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. CAYENNE MEDICAL
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. TORNIER
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
LIST OF TABLES
1. GLOBAL SOFT-TISSUE REPAIR MARKET BY APPLICATION 2014-2023 ($ MILLION)
2. GLOBAL DURAL REPARATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL HERNIA REPAIR MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL SKIN REPARATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL ORTHOPAEDICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL VAGINAL SLING PROCEDURES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL DENTAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL BREAST REFORM PROCEDURE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL SOFT-TISSUE REPAIR MARKET BY PRODUCT 2014-2023 ($ MILLION)
10. GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL TISSUE PATCH MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL SOFT TISSUE FIXATION DEVICE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL OTHER PRODUCTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL SOFT-TISSUE REPAIR MARKET BY END USER 2014-2023 ($ MILLION)
15. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL AMBULATORY SURGICAL CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. GLOBAL CLINICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. GLOBAL OTHER END USERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
19. NORTH AMERICA SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
20. EUROPE SOFT TISSUE REPAIR MARKET 2014-2023 ($ MILLION)
21. ASIA PACIFIC SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
22. REST OF THE WORLD SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
LIST OF FIGURES
1. GLOBAL DURAL REPARATION MARKET 2014-2023 ($ MILLION)
2. GLOBAL HERNIA REPAIR MARKET 2014-2023 ($ MILLION)
3. GLOBAL SKIN REPARATION MARKET 2014-2023 ($ MILLION)
4. GLOBAL ORTHOPAEDICS MARKET 2014-2023 ($ MILLION)
5. GLOBAL VAGINAL SLING PROCEDURES MARKET 2014-2023 ($ MILLION)
6. GLOBAL DENTAL MARKET 2014-2023 ($ MILLION)
7. GLOBAL BREAST REFORM PROCEDURE MARKET 2014-2023 ($ MILLION)
8. GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET 2014-2023 ($ MILLION)
9. GLOBAL TISSUE PATCH MARKET 2014-2023 ($ MILLION)
10. GLOBAL SOFT TISSUE FIXATION DEVICE MARKET 2014-2023 ($ MILLION)
11. GLOBAL OTHER PRODUCTS MARKET 2014-2023 ($ MILLION)
12. GLOBAL HOSPITALS MARKET BY GEOGRPHY 2014-2023 ($ MILLION)
13. GLOBAL AMBULATORY SURGICAL CENTERS MARKET BY GEOGAPHY 2014-2023 ($ MILLION)
14. GLOBAL CLINICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL OTHER END USERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. UNITED STATES (U.S.) SOFT TISSUE REPAIR MARKET 2014-2023 ($ MILLION)
17. CANADA SOFT TISSUE REPAIR MARKET 2014-2023 ($ MILLION)
18. UNITED KINGDOM (UK) SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
19. FRANCE SOFT TISSUE REPAIR MARKET 2014-2023 ($ MILLION)
20. GERMANY SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
21. SPAIN SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
22. ROE SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
23. INDIA SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
24. CHINA SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
25. JAPAN SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
26. AUSTRALIA SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
27. ROAPAC SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
28. LATIN AMERICA SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)
29. MENA SOFT-TISSUE REPAIR MARKET2014-2023 ($ MILLION)